Tuesday, April 30, 2019 2:15:24 AM
Technically, if Alphaeon violates the covenants of the loan agreement, the creditors can instantly sell it. Usually Stock based loans or "SBLOC's" are set up so the creditor can instantly sell. First the creditor notifies the debtor that they need to increase collateral, then if they don't, they have full rights to sell all of the collateral
Recent EOLS News
- Evolus to Report First Quarter Financial Results on May 7, 2024 • Business Wire • 04/23/2024 08:30:00 PM
- Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau® • Business Wire • 04/17/2024 08:05:00 PM
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/12/2024 08:05:00 PM
- Evolus to Participate in the 23rd Annual Needham Virtual Healthcare Conference • Business Wire • 03/26/2024 12:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/11/2024 01:00:48 PM
- Evolus Announces Pricing of $50.0 Million Underwritten Offering of Common Stock • Business Wire • 03/11/2024 11:00:00 AM
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/08/2024 09:05:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/07/2024 09:58:20 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/07/2024 09:42:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:09:47 PM
- Evolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 Guidance • Business Wire • 03/07/2024 09:05:00 PM
- Evolus Announces Results from European Head-to-Head Filler Trial • Business Wire • 03/01/2024 01:30:00 PM
- Evolus to Participate in Upcoming Leerink Partners and Barclays Investor Conferences • Business Wire • 02/27/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2024 01:27:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2024 01:27:32 AM
- Evolus to Report Fourth Quarter and Year End 2023 Results and Provide Business Update on March 7, 2024 • Business Wire • 02/22/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 11:37:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 11:37:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 11:37:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 11:36:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 11:36:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 11:35:53 PM
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 02/09/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:57:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/30/2024 09:09:53 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM